Clinical Trial Update: Neoadjuvant Therapy （NALIRIFOX） for Locally Advanced Colon and Upper Rectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating neoadjuvant therapy with NALIRIFOX (liposomal irinotecan with fluorouracil/leucovorin) for locally advanced colon and u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Affiliated Cancer Hospital of Shantou University Medical College | Conditions: Colorectal Cancer (CRC) | Phase 4 | Status: ACTIVE_NOT_RECRUITING